Results 11 to 20 of about 548,458 (391)

Polycystic liver disease: a clinical review

Annals of Hepatology, 2012
Polycystic liver disease rarely occurs in isolation as part of autosomal dominant polycystic liver disease, but more commonly, it exists as an extra-renal manifestation of autosomal dominant polycystic kidney disease. The pathogenesis of polycystic liver
Natasha Chandok, M.D., MPH, FRCPC
doaj   +5 more sources

Polycystic liver disease with lethal abdominal wall rupture: a case report [PDF]

Journal of Medical Case Reports, 2021
Background Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney.
Daichi Akuzawa, Yoichiro Uchida, Takuya Ishimura, Hiroko Kakita, Tomomi Endo, Naomi Matsuzaki, Hiroaki Terajima, Tatsuo Tsukamoto   +7 more
doaj   +2 more sources

A Classification-Based Adaptive Segmentation Pipeline: Feasibility Study Using Polycystic Liver Disease and Metastases from Colorectal Cancer CT Images. [PDF]

J Imaging Inform Med
Automated segmentation tools often encounter accuracy and adaptability issues when applied to images of different pathology. The purpose of this study is to explore the feasibility of building a workflow to efficiently route images to specifically trained segmentation models.
Wang P, Kline TL, Missert AD, Cook CJ, Callstrom MR, Chan A, Hartman RP, Kelm ZS, Korfiatis P.   +8 more
europepmc   +2 more sources

Polycystic liver disease: An uncommon genetic condition [PDF]

Clinical Case Reports
Key Clinical Message Timely recognition, accurate diagnosis, and proper management are vital for preventing complications and improving outcomes in polycystic liver disease. Abstract Polycystic liver disease is an uncommon genetic condition characterized
Faten Limaiem, Mohamed Hajri
doaj   +2 more sources

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials

Scientific Reports, 2021
A clear evidence on the benefits of somatostatin analogues (SA) on liver outcome in patients affected by polycystic liver disease is still lacking. We performed a meta-analysis of RCTs and a trial sequential analysis (TSA) evaluating the effects of SA in
Carlo Garofalo, Ivana Capuano, Luigi Pennino, Ilaria De Gregorio, Eleonora Riccio, Michele Provenzano, Felice Crocetto, Pasquale Buonanno, Savio Domenico Pandolfo, Michele Andreucci, Antonio Pisani   +10 more
doaj   +2 more sources

Liver Transplantation for Polycystic Liver Disease [PDF]

Archives of Surgery, 1990
Four female patients with severe complications of polycystic liver disease were treated with liver replacement; two patients were also given kidneys from their liver donors. All four of the patients were suffering from extreme fatigue.
Gordon, R, Mieles, L, Reyes, J, Starzl, TE, Todo, S, Tzakis, A   +5 more
core   +4 more sources

Novel GANAB variants associated with polycystic liver disease. [PDF]

Orphanet J Rare Dis, 2020
Background Polycystic liver disease (PLD) is an inherited disorder characterized by numerous cysts in the liver. Autosomal dominant polycystic kidney and liver disease (ADPKD and ADPLD, respectively) have been linked to pathogenic GANAB variants.
van de Laarschot LFM, Te Morsche RHM, Hoischen A, Venselaar H, Roelofs HM, Cnossen WR, Banales JM, Roepman R, Drenth JPH.   +8 more
europepmc   +2 more sources

Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis [PDF]

JHEP Reports, 2022
Background & Aims: Polycystic liver disease (PLD) manifests as numerous fluid-filled cysts scattered throughout the liver parenchyma. PLD most commonly develops in females, either as an extra-renal manifestation of autosomal-dominant polycystic ...
Dana Sierks, Ria Schönauer, Anja Friedrich, Elena Hantmann, Jonathan de Fallois, Nikolas Linder, Janett Fischer, Adam Herber, Carsten Bergmann, Thomas Berg, Jan Halbritter   +10 more
doaj   +2 more sources

Management of Polycystic Liver Disease [PDF]

Canadian Journal of Gastroenterology, 2004
Polycystic liver disease (PCLD) is characterized by multiple cysts throughout the liver. Patients may develop chronic intractable symptoms that may be debilitating. Others may develop medical complications that necessitate intervention.
Justin Cheung, Charles H Scudamore, Eric M Yoshida   +2 more
doaj   +3 more sources

Treatment of polycystic liver disease: a hypothesis, patient characteristics, short and long-term results

Annals of Hepatology, 2013
Background. Non-total liver resecting invasive treatment of polycystic liver disease has different recurrence rates. The aim of this study is to illustrate why the recurrence rates are different.
Zheng Long-Xian, Liu Ai-Wu, Qin Hua-Dong, Cui Jun, Jiang Hui-Jie, Jia Hong-Bo   +5 more
doaj   +2 more sources